- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Machine Learning Improves Glycemic Event Prediction in Diabetes
Last updated July 5, 2026
Key finding
Simulated evaluations confirmed improved postprandial time-in-range and reduced hypoglycemia.
This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.
Clinical relevance
These findings highlight the potential of machine learning tools in managing Type 1 Diabetes, which can lead to better glycemic control and improved quality of life for patients. By reducing the risks associated with postprandial glycemic events, this approach may help prevent complications related to diabetes.
Keep in mind
Non-randomized design may introduce bias. Limited generalizability due to specific population characteristics. Effectiveness of the intervention remains unclear in broader contexts.
Published in
Journal Reference
Publication details and source links for this paper.
Najib UR, Ivan C, Aleix B, Josep V, Luiz OA. Explainable Machine Learning Framework for Predicting Postprandial Glycemic Events in Type 1 Diabetes. PLOS Digital Health. 2025;4(9):e0000996. doi:10.1371/journal.pdig.0000996
Main Effects
Postprandial hypoglycemia incidence reduced by 0.5 events (p=0.01).
Postprandial hyperglycemia incidence reduced by 0.4 events (p=0.02).
Mean blood glucose levels decreased by 10.5 mg/dL (p=0.001).
Time in range increased by 15% (p=0.005).
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Insulin adjustment module and Blood glucose, Postprandial hyperglycemia incidence, Postprandial hypoglycemia incidence, and 1 more.
This study contributes evidence to
Primary intervention
Insulin adjustment module
Primary outcomes
- Blood glucose
- Postprandial hyperglycemia incidence
- Postprandial hypoglycemia incidence
Evidence topics
Primary intervention
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
1
Related topics
4
Evidence pairs
245
Related studies
Why it is useful
- Contributes to 4 evidence relationships
- Includes primary outcome data
- Linked to 1 direct semantic evidence topic
Topic contributions
Evidence topic
Contributes evidence
Add related evidence to your Evidence Tracker
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Smart Insulin Dosage Software and CGM Time in Range
Related evidence
Evidence relationship
Smart Insulin Dosage Software and Fasting Glucose
Save evidence
Evidence relationship
Smart Insulin Dosage Software and Hypoglycemia
Save evidence
Core evidence
Study findings
The primary outcomes reported in this study.
Postprandial hyperglycemia incidence
Insulin adjustment module → Postprandial hyperglycemia incidence
Insulin adjustment module → Postprandial hyperglycemia incidence
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Postprandial hypoglycemia incidence
Insulin adjustment module → Postprandial hypoglycemia incidence
Insulin adjustment module → Postprandial hypoglycemia incidence
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- Postprandial hypoglycemia incidence decreased by 0.5 events.
- Mean blood glucose levels decreased significantly by 10.5 mg/dL.
- Time in range improved by 15%.
Who this applies to
- Individuals with Type 1 Diabetes.
- Patients experiencing postprandial glycemic fluctuations.
Keep in Mind
- Results may not apply to all diabetes populations.
- Further research needed to confirm findings in diverse settings.
- The study did not measure long-term outcomes or complications.
Between the Lines
- Non-randomized design may introduce bias.
- Limited generalizability due to specific population characteristics.
- Effectiveness of the intervention remains unclear in broader contexts.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Smart Insulin Dosage Software and Fasting Glucose, Smart Insulin Dosage Software and Postprandial hyperglycemia incidence.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Smart Insulin Dosage Software → Fasting Glucose
Devices & Technology
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Smart Insulin Dosage Software → Postprandial hyperglycemia incidence
Devices & Technology
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Included in these evidence collections
Curated evidence collections and hubs this study is part of.
Fasting Glucose Evidence Hub
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
Postprandial hyperglycemia incidence Evidence Hub
All studies measuring Postprandial hyperglycemia incidence
Measures Postprandial hyperglycemia incidence as a key outcome.
Smart Insulin Dosage Software Evidence Hub
All studies on Smart Insulin Dosage Software
Contributes to Smart Insulin Dosage Software evidence base.
Recent Diabetes Research
Latest published studies
Published within the last 2 years.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Insulin adjustment module and Blood glucose
1 results
All studies on Insulin adjustment module and Postprandial hyperglycemia incidence
1 results
All studies on Insulin adjustment module
1 results
All studies measuring Blood glucose
1 results
All studies measuring Postprandial hyperglycemia incidence
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Smart Insulin Dosage Software improve cgm time in range?
Smart Insulin Dosage Software may worsen CGM Time in Range or be associated with harm.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 3 supporting studies and existing graph evidence signals.
Limitations
- Population details are unavailable.
Does Smart Insulin Dosage Software improve fasting glucose?
Smart Insulin Dosage Software may improve Fasting Glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Blood glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
- Population details are unavailable.
Does Smart Insulin Dosage Software affect hypoglycemia?
Current evidence does not show a clear benefit of Smart Insulin Dosage Software for Hypoglycemia.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Postprandial hypoglycemia incidence
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Insulin adjustment module improve postprandial hyperglycemia incidence?
Current evidence does not show a clear benefit of Insulin adjustment module for Postprandial hyperglycemia incidence.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Postprandial hyperglycemia incidence
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.
